Ardelyx, Inc. (ARDX) Dividend History

Ardelyx, Inc. (ARDX) is a biotechnology company focused on developing and commercializing novel treatments for cardio-renal and gastrointestinal diseases. Founded to address unmet medical needs, Ardelyx's portfolio includes therapies targeting conditions such as chronic kidney disease, constipation, and other gastrointestinal disorders.

34175 Ardenwood Blvd., Fremont, CA, 94555
Phone: 510-745-7047
Website: https://www.ardelyx.com

Dividend History

Ardelyx, Inc. currently does not pay dividends

Company News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - CABO

Cable One reported disappointing Q1 2025 earnings, missing analyst expectations and suspending its dividend. The stock price fell over 40% on this news, leading Pomerantz LLP to investigate potential securities fraud or other unlawful business practices by the company and its officers/directors.

GlobeNewswire Inc.

Featured Companies: CABO IART
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025

Ardelyx, a biopharmaceutical company, announced that it will present data supporting its product IBSRELA (tenapanor) at the Digestive Disease Week 2025 Conference.

GlobeNewswire Inc.
Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference

Ardelyx, a biopharmaceutical company, announced that it will present data on its IBS-C drug IBSRELA and results from the IBS in America 2024 survey at the upcoming Digestive Disease Week Conference.

GlobeNewswire Inc.
Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

Ardelyx, a biopharmaceutical company, announced that it will present at the TD Cowen's 45th Annual Health Care Conference on March 3, 2025. The company has two commercial products approved in the U.S. and has agreements for the development and commercialization of its product tenapanor outside the U.S.

GlobeNewswire Inc.
Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Ardelyx, a biopharmaceutical company, announced that its President and CEO, Mike Raab, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 20:09:10 UTC